Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Metastasis02:30

Metastasis

6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer02:18

Cancer

53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease.

Nature genetics·2026
Same author

Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease.

bioRxiv : the preprint server for biology·2026
Same author

Microenvironmentally derived fatty acid-binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma.

Blood neoplasia·2026
Same author

Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells.

Journal of experimental & clinical cancer research : CR·2026
Same author

Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes.

Bone reports·2025
Same author

Correction: Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.

Cancer research·2025

Related Experiment Video

Updated: Jan 19, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K

Cancer Cell Dormancy in Metastasis.

Matthew A Summers1,2, Michelle M McDonald1,2, Peter I Croucher1,2

  • 1Bone Biology, The Garvan Institute of Medical Research, Sydney 2010 NSW, Australia.

Cold Spring Harbor Perspectives in Medicine
|September 25, 2019
PubMed
Summary

Dormant cancer cells can cause recurrent metastasis years after treatment. Understanding how these cells enter and exit dormancy is key to developing new therapies that prevent cancer relapse.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K
A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.8K

Related Experiment Videos

Last Updated: Jan 19, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K
A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.8K

Area of Science:

  • Oncology
  • Cancer Biology
  • Metastasis Research

Background:

  • Recurrent metastasis is a major cause of cancer mortality.
  • Disseminated tumor cells can enter a dormant state, evading therapy.
  • Reactivation of dormant cells leads to lethal metastatic disease.

Purpose of the Study:

  • To review the mechanisms of disseminated tumor cell dormancy in recurrent metastasis.
  • To highlight the role of microenvironmental niches in dormancy.
  • To discuss therapeutic strategies for eradicating residual disease.

Main Methods:

  • Literature review of mechanisms controlling tumor cell dormancy.
  • Analysis of microenvironmental factors influencing dormant cells.
  • Discussion of emerging therapeutic approaches.

Main Results:

  • Tumor cells escape the primary site early and colonize distant organs.
  • Dormancy is a survival mechanism for disseminated tumor cells.
  • Specific microenvironments (niches) support dormant cell survival.
  • Poorly understood mechanisms drive dormant cell reactivation.
  • Emerging therapies aim to target residual disease.

Conclusions:

  • Disseminated tumor cell dormancy is a critical factor in cancer recurrence.
  • Understanding dormancy and reactivation mechanisms is essential for preventing metastasis.
  • Targeting dormant cells and their niches offers potential for novel cancer therapies.